Table 2.

Comparison of left ventricular function and rehospitalization rate between sacubitril valsartan group and valsartan group after 12 months of treatment.

Characteristic	Salkubatroxartan group (84)	Valsartan group (86)	t orχ2	P
LVEF (%), mean ± SD	54.76 ± 4.24	49.28 ± 3.47	9.235	<.001
LVDD (mm), mean ± SD	47.26 ± 4.71	50.12 ± 5.62	−3.643	<.001
Readmission rate, n (%)	6 (7.14%)	16 (18.60%)	0.026	.038

LVDD = left ventricular end diastolic dimension, LVEF = left ventricular ejection fraction.